# Quetta Acquisition Corp: financial statements, quarterly QETA · OTC · CIK 1978528 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/qeta.md) · [Financials](/companies/qeta/financials.md) · [Filings](/companies/qeta/filings.md) · [Insiders](/companies/qeta/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qeta/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2022-09-30) | Q3 FY2024 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating income | $k | not reported | not reported | [(123)](/filings/0001641172-25-008338.md) | [(198)](/filings/0001493152-25-012161.md) | [(146)](/filings/0001493152-25-022647.md) | [(344) d](/filings/0001493152-26-018655.md) | [(417)](/filings/0001493152-26-023415.md) | [(764)](/filings/0001493152-26-038398.md) | [(194)](/filings/0001493152-25-022647.md) | [(92.3) d](/filings/0001493152-26-018655.md) | [(150)](/filings/0001493152-26-023415.md) | [(232)](/filings/0001493152-26-038398.md) | | Income tax | $k | not reported | not reported | [191](/filings/0001641172-25-008338.md) | [193](/filings/0001493152-25-012161.md) | [195](/filings/0001493152-25-022647.md) | [176 d](/filings/0001493152-26-018655.md) | [56.7](/filings/0001493152-26-023415.md) | [37.5](/filings/0001493152-26-038398.md) | [37.1](/filings/0001493152-25-022647.md) | [35.7 d](/filings/0001493152-26-018655.md) | [33.5](/filings/0001493152-26-023415.md) | [34.3](/filings/0001493152-26-038398.md) | | Net income | $k | [2.9](/filings/0001829126-23-007424.md) | [2.9](/filings/0001829126-24-007239.md) | [612](/filings/0001493152-25-022647.md) | [544](/filings/0001493152-25-022647.md) | [604](/filings/0001493152-25-022647.md) | [334 d](/filings/0001493152-26-018655.md) | [(194)](/filings/0001493152-26-038398.md) | [(608)](/filings/0001493152-26-038398.md) | [(34.9)](/filings/0001493152-25-022647.md) | [55.6 d](/filings/0001493152-26-018655.md) | [(13.5)](/filings/0001493152-26-038398.md) | [885](/filings/0001493152-26-038398.md) | - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss ## Balance sheet | Line item | Unit | Q3 FY2024 (2023-09-30) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.0](/filings/0001829126-23-007424.md) | [0.0](/filings/0001829126-24-007239.md) | [0.0](/filings/0001829126-24-003032.md) | [0.0](/filings/0001829126-24-005182.md) | [0.0](/filings/0001829126-24-007239.md) | [1.6](/filings/0001493152-26-018655.md) | [0.2](/filings/0001641172-25-008338.md) | [0.2](/filings/0001493152-25-012161.md) | [0.0](/filings/0001493152-25-022647.md) | [0.0](/filings/0001493152-26-038398.md) | [0.0](/filings/0001493152-26-023415.md) | [0.0](/filings/0001493152-26-038398.md) | | Current assets | $m | not reported | [0.7](/filings/0001641172-25-002974.md) | [0.7](/filings/0001829126-24-003032.md) | [0.4](/filings/0001829126-24-005182.md) | [0.4](/filings/0001829126-24-007239.md) | [1.6](/filings/0001493152-26-018655.md) | [0.3](/filings/0001641172-25-008338.md) | [0.3](/filings/0001493152-25-012161.md) | [0.1](/filings/0001493152-25-022647.md) | [0.0](/filings/0001493152-26-038398.md) | [0.0](/filings/0001493152-26-023415.md) | [0.1](/filings/0001493152-26-038398.md) | | Total assets | $m | [0.4](/filings/0001829126-23-007424.md) | [71.2](/filings/0001641172-25-002974.md) | [72.1](/filings/0001829126-24-003032.md) | [72.8](/filings/0001829126-24-005182.md) | [73.7](/filings/0001829126-24-007239.md) | [74.7](/filings/0001493152-26-018655.md) | [18.7](/filings/0001641172-25-008338.md) | [19.0](/filings/0001493152-25-012161.md) | [19.0](/filings/0001493152-25-022647.md) | [19.3](/filings/0001493152-26-038398.md) | [19.6](/filings/0001493152-26-023415.md) | [20.0](/filings/0001493152-26-038398.md) | | Current liabilities | $m | [0.4](/filings/0001829126-23-007424.md) | [0.2](/filings/0001641172-25-002974.md) | [0.5](/filings/0001829126-24-003032.md) | [0.7](/filings/0001829126-24-005182.md) | [0.9](/filings/0001829126-24-007239.md) | [1.6](/filings/0001493152-26-018655.md) | [1.5](/filings/0001641172-25-008338.md) | [2.5](/filings/0001493152-25-012161.md) | [2.5](/filings/0001493152-25-022647.md) | [2.7](/filings/0001493152-26-038398.md) | [3.0](/filings/0001493152-26-023415.md) | [2.5](/filings/0001493152-26-038398.md) | | Total liabilities | $m | not reported | [2.6](/filings/0001641172-25-002974.md) | [2.9](/filings/0001829126-24-003032.md) | [3.1](/filings/0001829126-24-005182.md) | [3.3](/filings/0001829126-24-007239.md) | [4.0](/filings/0001493152-26-018655.md) | [3.9](/filings/0001641172-25-008338.md) | [4.9](/filings/0001493152-25-012161.md) | [4.9](/filings/0001493152-25-022647.md) | [5.1](/filings/0001493152-26-038398.md) | [5.4](/filings/0001493152-26-023415.md) | [4.9](/filings/0001493152-26-038398.md) | | Short-term borrowings | $m | not reported | [0.0](/filings/0001641172-25-002974.md) | not reported | not reported | not reported | [0.0](/filings/0001493152-26-018655.md) | [0.0](/filings/0001641172-25-008338.md) | [0.0](/filings/0001493152-25-012161.md) | [0.0](/filings/0001493152-25-022647.md) | [0.0](/filings/0001493152-26-038398.md) | [0.0](/filings/0001493152-26-023415.md) | [0.0](/filings/0001493152-26-038398.md) | | Shareholders' equity | $m | [0.0](/filings/0001829126-24-007239.md) | [(1.7)](/filings/0001493152-26-018655.md) | [(1.8)](/filings/0001493152-25-022647.md) | [(2.0)](/filings/0001493152-25-022647.md) | [(2.1)](/filings/0001493152-25-022647.md) | [(2.5)](/filings/0001493152-26-038398.md) | [(3.6)](/filings/0001493152-26-038398.md) | [(4.5)](/filings/0001493152-26-038398.md) | [(4.9)](/filings/0001493152-25-022647.md) | [(5.1)](/filings/0001493152-26-038398.md) | [(5.5)](/filings/0001493152-26-038398.md) | [(4.8)](/filings/0001493152-26-038398.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(44.4)](/filings/0001641172-25-008338.md) | [(231) d](/filings/0001493152-25-012161.md) | [(5.0) d](/filings/0001493152-25-022647.md) | [(304) d](/filings/0001493152-26-018655.md) | [(1,381)](/filings/0001493152-26-023415.md) | [(201) d](/filings/0001493152-26-038398.md) | [(295) d](/filings/0001493152-25-022647.md) | [48.6 d](/filings/0001493152-26-018655.md) | [(47.5)](/filings/0001493152-26-023415.md) | [(346) d](/filings/0001493152-26-038398.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities Shares outstanding: 3,747,748 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038398.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.